Clinical Trials Browser

Has results × Lymphoma, Non-Hodgkin × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

Hodgkin Disease, Leukemia, Leukemia, Lymphoid, Lymphoma, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT01158118 2017-06-05

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

Phase 2 Completed

48 enrolled 17 charts

LymphoidMyeloidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00499343 2013-08-02

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients

Phase 2 Completed

84 enrolled 5 charts

Lymphoid

Lymphoma, Lymphoma, Non-Hodgkin

Clinical Trials

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis

Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors

G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients